| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/26/2007 | EP1836314A2 Modified human growth hormone |
| 09/26/2007 | EP1836296A1 X-ray structure of human fpps and use for selecting fpps binding compounds |
| 09/26/2007 | EP1836224A1 Bcma polypeptides and uses thereof |
| 09/26/2007 | EP1836216A1 Binding partners of antibodies specific for dendritic cell antigens |
| 09/26/2007 | EP1835930A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 09/26/2007 | EP1835929A2 Anti-kir combination treatments and methods |
| 09/26/2007 | EP1835928A2 Mas related g protein coupled receptors as drug targets |
| 09/26/2007 | EP1835927A1 Modified beta thymosin peptides |
| 09/26/2007 | EP1835926A2 Plasmin-inhibitory therapies |
| 09/26/2007 | EP1835889A1 Nanoparticulate tacrolimus formulations |
| 09/26/2007 | EP1835885A1 Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh |
| 09/26/2007 | EP1610802A4 Parkin interacting polypeptides and methods of use |
| 09/26/2007 | EP1578909A4 Excitatory glycine receptors and methods |
| 09/26/2007 | EP1554250B1 Novel lactams and uses thereof |
| 09/26/2007 | EP1501485B1 High drug load tablet |
| 09/26/2007 | EP1417223B1 Process for preparing lipid ii |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1411951B1 Enteral compositions for the prevention and/or treatment of sepsis |
| 09/26/2007 | EP1409740B1 Asthma-associated gene |
| 09/26/2007 | EP1272510B1 Pharmacologically active antiviral peptides and methods of their use |
| 09/26/2007 | EP1265596B1 Medical emulsion for lubrication and delivery of drugs |
| 09/26/2007 | EP1237571B1 Toscana virus nucleoprotein |
| 09/26/2007 | EP1222255B1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 09/26/2007 | EP1198250B1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 09/26/2007 | EP1198239B1 METHODS EMPLOYING BACTERIAL ParD kis/ParD kid TOXIN-ANTITOXIN SYSTEM FOR KILLING EUKARYOTIC CELLS |
| 09/26/2007 | EP1194447B1 Novel potassium channels and genes encoding these potassium channels |
| 09/26/2007 | EP1153131B1 Compositions for gene therapy of diabetes |
| 09/26/2007 | EP1141005B1 Method for identifying hif-1alpha modulators |
| 09/26/2007 | EP1047708B1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center |
| 09/26/2007 | EP1035865B1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/26/2007 | EP1025212B1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 09/26/2007 | EP0937140B1 Antibody molecules which interact specifically with the active site or cleft of a target molecule |
| 09/26/2007 | EP0787191B1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 09/26/2007 | CN101044242A Tumor specific antibody |
| 09/26/2007 | CN101044239A Mammalian cell culture processes for protein production |
| 09/26/2007 | CN101044162A Glp-1 analog fusion protein formulations |
| 09/26/2007 | CN101044160A Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 09/26/2007 | CN101044158A Chemokine binding activity of viral TNF receptors and related proteins |
| 09/26/2007 | CN101044157A Compounds for proteasome enzyme inhibition |
| 09/26/2007 | CN101044154A Chimeric molecules for cleavage in a treated host |
| 09/26/2007 | CN101043901A Method for preventing and treating alzheimer's disease |
| 09/26/2007 | CN101043900A 肽混合物 Peptide mixture |
| 09/26/2007 | CN101043899A Refolding transforming growth factor beta family proteins |
| 09/26/2007 | CN101041818A Method for recombinant production of pancreatic glucagons sample peptide-2 |
| 09/26/2007 | CN101041694A Angiogenin-like protein V and preparation method thereof, its polyclonal antibody and uses thereof |
| 09/26/2007 | CN101041693A Novel blood sugar lowing polypeptide and uses thereof |
| 09/26/2007 | CN101041692A Scorpion analgesic antibacterial active peptide and preparation method thereof |
| 09/26/2007 | CN101041691A Chinese south China sea signal taro snail nerve toxin gene 1t5.4 and uses thereof |
| 09/26/2007 | CN101041690A Recombinant dog hookworm coagulate peptide resistant 5 mutant, its encoding gene, preparation and application thereof |
| 09/26/2007 | CN101041689A Derivative of cyclosporins C and D and pharmaceutical composition thereof |
| 09/26/2007 | CN101041687A PGE2 differential combined phage lambda ring seven peptide and sifting method and usage of synthesized peptide |
| 09/26/2007 | CN101041686A Wood frog anticancer peptide and preparation method thereof |
| 09/26/2007 | CN101041079A Novel colloid synthetic vectors for gene therapy |
| 09/26/2007 | CN101041073A Application of proteinase inhibitor in protecting pancreas cells |
| 09/26/2007 | CN101041072A The function and application of proteinase Inhibitor for protecting cardiac muscle cells |
| 09/26/2007 | CN101041071A Interacted proteins of APC10 and the function for adjusting the cell period thereof |
| 09/26/2007 | CN101041070A Compound for preventing and treating radiation damage and the preparing method |
| 09/26/2007 | CN101041069A Preparation for beauty and for supplementing blood |
| 09/26/2007 | CN101041068A Preparation for beauty and for supplementing zinc |
| 09/26/2007 | CN101041067A Preparation for beauty and for adjusting the immunity |
| 09/26/2007 | CN101041066A The function of r-sHSA for treating chronic liver disease |
| 09/26/2007 | CN101041065A Method for preparing Duyiwei compound injection |
| 09/26/2007 | CN101041064A Medicine-Weigaisan for treating children's diarrhoea and the preparing method |
| 09/26/2007 | CN101041063A Polypeptide from faliotidae oral medicine agent and the preparing technique |
| 09/26/2007 | CN101041062A Anti-hepatitis B virus ascidians polypeptide medicine composition and the preparing method |
| 09/26/2007 | CN101041061A Anti-hepatitis B virus medicine agent and its preparing process |
| 09/26/2007 | CN101041060A Method for preparing encephalon glycoside and ignotin injection and the agent thereof |
| 09/26/2007 | CN101040839A Anticancer compound carrying phosphatidylinostitol 3-kinase inhibitor and the synergistic agent thereof |
| 09/26/2007 | CN100339482C Hybrid expression of neisserial proteins |
| 09/26/2007 | CN100339478C Methanol yeast recombination expression liver regeneration enhancement factor and its mutant |
| 09/26/2007 | CN100339396C Multi-helix protein for inhibiting membrane virus infection, its coding gene and use |
| 09/26/2007 | CN100339395C E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 09/26/2007 | CN100339394C 组织特异性表达 Tissue-specific expression |
| 09/26/2007 | CN100339392C Liver cancer apoptosis inducing factor and its encoding gene and use |
| 09/26/2007 | CN100339390C Coronavirus specific T-cellantigen determinate cluster |
| 09/26/2007 | CN100339389C 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 09/26/2007 | CN100339387C Method for preparing antler polypeptide and medicine with the antler polypeptide as main active component |
| 09/26/2007 | CN100339133C Composition of nanometer SOD and astragalus root or its extract and its preparation method |
| 09/26/2007 | CN100339132C Antithrombotic agents |
| 09/26/2007 | CN100339129C Use of dalbavancin compositions in preparation of medicament for treatment of bacterial infections |
| 09/26/2007 | CN100339066C Stable injecta composition and method |
| 09/25/2007 | US7273964 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 09/25/2007 | US7273951 Polyhydroxy phenols and their use in binding p-selectin |
| 09/25/2007 | US7273932 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
| 09/25/2007 | US7273929 B1k chain of laminin and methods of use |
| 09/25/2007 | US7273928 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 09/25/2007 | US7273926 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 09/25/2007 | US7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses |
| 09/25/2007 | US7273920 Controlling protein levels in eucaryotic organisms |
| 09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273854 Recombinant adenovirus, adeno-associated virus or herpes virus (especially a replication defective virus) containing a nucleic acid of a specific sequence encoding an antisense RNA that inhibits expression of p53. |
| 09/25/2007 | US7273851 Tri-peptide hepatitis C serine protease inhibitors |
| 09/25/2007 | US7273850 Administering to the cell all or part of a peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for inhibiting calcium uptake by a cancer cell |
| 09/25/2007 | US7273849 ProapolipoproteinA-I mutant and pharmaceutical composition comprising the same for prevention and treatment of atherosclerosis and hyperlipidemia |
| 09/25/2007 | US7273848 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 09/25/2007 | US7273847 Peptides with antioxidant and antimicrobial properties |
| 09/25/2007 | US7273846 Selective melanin-concentrating hormone type-1 receptor agonists |
| 09/25/2007 | US7273845 vancomycin-polymer conjugate; polymer is attached to both of the vancomycin amino groups |
| 09/25/2007 | US7273844 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |